JinkoSolar to Report First Quarter 2025 Results on April 29, 2025
SHANGRAO,China,April 14,2025-- JinkoSolar Holding Co.,Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS),one of the largest and most innovative solar module manufacturers in the worl
SKF completes previously announced divestment of its ring and seal operation in Hanover, USA
GOTHENBURG,Sweden,April 14,2025-- SKF has completed the previously announced divestment of its ring and seal operation in Hanover,Pennsylvania,USA,to Carco PRP Group for a total enterprise value of US
WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards
SHANGHAI,April 14,2025-- WuXi Biologics ("WuXi Bio") (2269.HK),a leading global Contract Research,Development and Manufacturing Organization (CRDMO),announced that it has received five award
Puneet Malhotra Joins Personetics as Chief Revenue Officer
Malhotra\'s experience as a growth leader will fuel Personetics\' global expansion in the new Cognitive Banking era
Nature's Miracle Holding Inc. Announces Up to $2,000,000 Financing
ONTARIO,Calif.,April 15,2025-- Nature\'s Miracle Holding Inc. (NMHI) ("Nature\'s Miracle" or the "Company"),a leader in vertical farming technology,today announced that on April 11
HONG KONG and SHANGHAI,April 15,2025-- On April 14,the 2025 Hainan Free Trade Port Global Investment Promotion Conference was held in Haikou. Jointly hosted by the People\'s Government of Hainan Provi
NetEase, Inc. Announces Filing of Annual Report on Form 20-F for Fiscal Year 2024
HANGZHOU,China,April 15,2025-- NetEase,Inc.(NASDAQ: NTES and HKEX: 9999,"NetEase" or "the Company"),a leading internet and game services provider,today announced that it filed its
Acer Debuts Nitro Gaming PCs Featuring Latest NVIDIA GeForce RTX 50 Series GPUs
New Acer Nitro AI laptops with slim options and the Nitro 20 desktop offer solid performance and essential AI capabilities,supported by new NVIDIA GeForce RTX 5060 GPUs
Pilatus Biosciences to Present Research on PLT012 at AACR 2025
Novel Immunometabolism Approach Targets Immune-Cold Solid Tumors DOVER,Del. and EPALINGES,Switzerland,April 15,2025-- Pilatus Biosciences,pioneering biologics targeting metabolic checkpoints,will pres
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
MELBOURNE,Australia and INDIANAPOLIS,April 16,2025-- Telix Pharmaceuticals Limited (ASX: TLX,NASDAQ: TLX,Telix,the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX